Critics say a new, broader definition of high-risk plaque opens the door to more tests, diagnoses, and invasive procedures, steering us down a potentially harmful path.

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

This overexpression causes an age-dependent accumulation of Aβ plaques that are quantitatively and qualitatively similar to those of the AD brain, but does not reproduce the complete phenotype ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...